|

Halt Aging in Survivors of Blood Cancers

RECRUITINGPhase 2Sponsored by University of Nebraska
Actively Recruiting
PhasePhase 2
SponsorUniversity of Nebraska
Started2026-04-09
Est. completion2032-03-25
Eligibility
Age50 Years+
Healthy vol.Accepted
Locations1 site

Summary

Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist to implement exercise interventions in older survivors of blood cancer; the dose and duration of exercise necessary to slow biological aging in older blood cancer survivors remain unknown. To bridge these gaps in knowledge, we have designed a Phase 2 randomized control trial to test the effects of behavioral and exercise interventions on various outcomes.

Eligibility

Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Age ≥50 years
2. A history of hematological malignancy
3. Participants must be able to and willingly give informed consent

Exclusion Criteria:

1. Patients receiving intensive induction or consolidation chemotherapy. Maintenance chemotherapy, or lower-intensity chemotherapy for an indolent hematological malignancy is allowed.
2. Neurodegenerative disease (e.g. Alzheimer's dementia), stroke, or uncontrolled psychotic disorders (e.g. schizophrenia or bipolar disorder) in the past 3 months if those disorders are considered significant enough to impair participation in the study.
3. Illnesses such as clinical evidence of decompensated heart failure, unstable angina, or orthopedic or neuromuscular disorders that could limit safe participation in aerobic exercise.
4. Cardiopulmonary exercise test results that preclude safe exercise (e.g., life-threatening arrhythmia, balance difficulties, peak VO2 \<10 ml/kg/min).
5. Estimated life expectancy of less than 6 months (that precludes assessment of study primary endpoint).
6. Self-reported pregnancy or the possibility of pregnancy.
7. Participants who do not plan to follow up at the participating center.

Conditions9

CancerHematological MalignancyLeukemiaLymphoid LeukemiaMonocytic LeukemiaMultiple MyelomaMyeloid LeukemiaNon-hodgkin LymphomaOther Hematologic Condition

Locations1 site

University of Nebraska Medical Center
Omaha, Nebraska, 68008
IIT Office IIT Office402-559-4596IITOffice@unmc.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.